| 标题 |
[求助补充材料]
 Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
cdercder
Kao
Criminology34
asdasd
aajhajkahna
秋风
Ali
GingerF
舒适的如萱
印第安老斑鸠
FIN
初景
乐空思
Nole
arniu2008
DW
XX
St
皖公网安备34019202002308
